Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Somatostatin may help protect hair follicles from immune attacks.

Zinc may help treat alopecia areata by boosting certain immune cells.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.